Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 172

1.

Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer.

Zegarac M, Nikolic S, Gavrilovic D, Jevric M, Kolarevic D, Nikolic-Tomasevic Z, Kocic M, Djurisic I, Inic Z, Ilic V, Santrac N.

J BUON. 2013 Oct-Dec;18(4):859-65.

PMID:
24344009
[PubMed - indexed for MEDLINE]
2.

[Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].

Li Q, Xu BH, Zhang P, Li Q, Yuan P, Wang JY, Luo Y, Ma F, Fan Y, Li Q.

Zhonghua Zhong Liu Za Zhi. 2013 Mar;35(3):207-11. doi: 10.3760/cma.j.issn.0253-3766.2013.03.010. Chinese.

PMID:
23880002
[PubMed - indexed for MEDLINE]
3.

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.

BMC Cancer. 2007 Apr 12;7:63.

PMID:
17430582
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome.

Abbott DE, Brouquet A, Mittendorf EA, Andreou A, Meric-Bernstam F, Valero V, Green MC, Kuerer HM, Curley SA, Abdalla EK, Hunt KK, Vauthey JN.

Surgery. 2012 May;151(5):710-6. doi: 10.1016/j.surg.2011.12.017. Epub 2012 Jan 29.

PMID:
22285778
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer.

Gabos Z, Thoms J, Ghosh S, Hanson J, Deschênes J, Sabri S, Abdulkarim B.

Breast Cancer Res Treat. 2010 Nov;124(1):187-94. doi: 10.1007/s10549-010-1135-1. Epub 2010 Sep 3.

PMID:
20814819
[PubMed - indexed for MEDLINE]
6.

Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer.

Chen XS, Ma CD, Wu JY, Yang WT, Lu HF, Wu J, Lu JS, Shao ZM, Shen ZZ, Shen KW.

Tumori. 2010 Jan-Feb;96(1):103-10.

PMID:
20437866
[PubMed - indexed for MEDLINE]
7.

[Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].

Wang SL, Li YX, Song YW, Wang WH, Jin J, Liu YP, Liu XF, Yu ZH.

Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):520-5. Chinese.

PMID:
21029696
[PubMed - indexed for MEDLINE]
8.

[Clinical characteristics and potential prognostic factors of breast cancer patients with liver metastases].

Wang JY, Xu BH, Tian LJ, Wang Y.

Zhonghua Zhong Liu Za Zhi. 2006 Aug;28(8):612-6. Chinese.

PMID:
17236558
[PubMed - indexed for MEDLINE]
9.

Prolonged overall survival after pulmonary metastasectomy in patients with breast cancer.

Meimarakis G, Rüttinger D, Stemmler J, Crispin A, Weidenhagen R, Angele M, Fertmann J, Hatz RA, Winter H.

Ann Thorac Surg. 2013 Apr;95(4):1170-80. doi: 10.1016/j.athoracsur.2012.11.043. Epub 2013 Feb 4.

PMID:
23391172
[PubMed - indexed for MEDLINE]
10.

The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.

Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, Arik Z, Babacan T, Ozisik Y, Altundag K.

J BUON. 2013 Apr-Jun;18(2):335-41.

PMID:
23818343
[PubMed - indexed for MEDLINE]
11.

Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective study.

Bulent Akinci M, Algin E, Inal A, Odabas H, Berk V, Coskun U, Uyeturk U, Isikdogan A, Aksoy S, Civelek B, Sevinc A, Buyukberber S.

J BUON. 2013 Apr-Jun;18(2):314-20.

PMID:
23818340
[PubMed - indexed for MEDLINE]
12.

The importance of extracapsular extension of axillary lymph node metastases in breast cancer.

Ilknur GB, Hilmi A, Tülay C, Oguz C, Selma S, Serdar S, Uğur Y, Pinar B, Omer H, Münir K; Dokuz Eylül University Medical Faculty Breast Tumors Study Group.

Tumori. 2004 Jan-Feb;90(1):107-11.

PMID:
15143982
[PubMed - indexed for MEDLINE]
13.

Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.

Abdulkarim BS, Cuartero J, Hanson J, Deschênes J, Lesniak D, Sabri S.

J Clin Oncol. 2011 Jul 20;29(21):2852-8. doi: 10.1200/JCO.2010.33.4714. Epub 2011 Jun 13.

PMID:
21670451
[PubMed - indexed for MEDLINE]
Free Article
14.

[Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].

Fan Y, Guan Y, Zhao WH, Li Q, Xu BH.

Zhonghua Zhong Liu Za Zhi. 2008 Dec;30(12):917-20. Chinese.

PMID:
19173993
[PubMed - indexed for MEDLINE]
15.

Resection of liver metastases in patients with breast cancer: survival and prognostic factors.

van Walsum GA, de Ridder JA, Verhoef C, Bosscha K, van Gulik TM, Hesselink EJ, Ruers TJ, van den Tol MP, Nagtegaal ID, Brouwers M, van Hillegersberg R, Porte RJ, Rijken AM, Strobbe LJ, de Wilt JH; Dutch Liver Surgeons Group.

Eur J Surg Oncol. 2012 Oct;38(10):910-7. doi: 10.1016/j.ejso.2012.04.015. Epub 2012 Jun 7.

PMID:
22682709
[PubMed - indexed for MEDLINE]
16.

Clinicopathologic characteristics and prognostic factors in patients with operable HER-2 overexpressing breast cancer.

Liu AN, Sun P, Liu JN, Ma JB, Qu HJ, Zhu H, Yu CY, Zhang LM.

Asian Pac J Cancer Prev. 2012;13(4):1197-201.

PMID:
22799305
[PubMed - indexed for MEDLINE]
Free Article
17.

Endocrine therapy alone vs. chemotherapy plus endocrine therapies for the treatment of elderly patients with endocrine-responsive and node positive breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology).

Inal A, Akman T, Yaman S, Demir Ozturk S, Geredeli C, Bilici M, Inanc M, Harputoglu H, Demirci U, Balakan O, Yesil Cinkir H, Alici S, Uysal Sonmez O, Goksel G, Gokoz Dogu G, Umit Unal O, Tamozlu T, Buyukberber S, Melih Boruban C, Isikdogan A.

J BUON. 2013 Jan-Mar;18(1):64-9.

PMID:
23613390
[PubMed - indexed for MEDLINE]
18.

Integration of estrogen and progesterone receptors with pathological and molecular prognostic factors in breast cancer patients.

Gago FE, Tello OM, Diblasi AM, Ciocca DR.

J Steroid Biochem Mol Biol. 1998 Dec;67(5-6):431-7.

PMID:
10030692
[PubMed - indexed for MEDLINE]
19.

Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.

Yu H, Levesque MA, Clark GM, Diamandis EP.

Br J Cancer. 1999 Oct;81(3):490-5.

PMID:
10507775
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.

Lin YC, Chen SC, Chang HK, Hsueh S, Tsai CS, Lo YF, Hwang TL, Chen MF.

Jpn J Clin Oncol. 2005 Sep;35(9):514-9.

PMID:
16199422
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk